Related Experiment Video

Updated: Aug 6, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Paradigm Shifts in Cystic Fibrosis Newborn Screening and Care in Infancy

MacKenzie L Wyatt1, Jessica Clarion2, Meghan McGarry1

  • 1Division of Pulmonary and Sleep Medicine, Seattle Children's Hospital, Center for Respiratory Biology and Therapeutics, University of Washington, Seattle, WA, USA.

Advances in Pediatrics
|July 21, 2026
PubMed

Insights

Advances in cystic fibrosis (CF) care, including early detection and modulator therapies, have improved life expectancy. However, new challenges arise in interpreting tests and clinical signs for indeterminate CF diagnoses.

Area of Science:

  • Pediatric Pulmonology
  • Genetic Medicine
  • Clinical Diagnostics

Background:

  • Significant advancements in cystic fibrosis (CF) care have enabled early disease identification and intervention in early childhood.
  • The advent of universal screening and modulator therapies has revolutionized CF patient care, leading to improved life expectancy.
  • Current progress in CF management presents new complexities in diagnostic interpretation.

Purpose of the Study:

  • To address the uncertainty in interpreting diagnostic tests and clinical phenotypes for cystic fibrosis.
  • To explore the implications of modern CF care advancements on diagnostic clarity.
  • To provide insights into managing indeterminate CF diagnoses in light of evolving treatment landscapes.

Main Methods:

  • Review of current diagnostic protocols for cystic fibrosis.
  • Analysis of clinical phenotypes in the context of novel therapeutic interventions.
  • Evaluation of emerging challenges in interpreting diagnostic test results for CF.

Main Results:

  • Early identification and intervention strategies have markedly improved outcomes for children with CF.
  • Modulator therapies represent a paradigm shift in CF treatment, enhancing patient longevity.
  • Interpretation of diagnostic tests and clinical presentations can be indeterminate, posing challenges for definitive CF diagnosis.

Conclusions:

  • While CF care has advanced, indeterminate diagnostic results require careful consideration.
  • The evolving landscape of CF treatment necessitates updated approaches to diagnosis and interpretation.
  • Further research is needed to refine diagnostic criteria and management strategies for ambiguous CF cases.

Keywords:
Cystic fibrosis (CF)Cystic fibrosis screen positiveCystic fibrosis transmembrane conductance regulator (CFTR)-Related metabolic syndrome (CRMS)Health equityHighly effective modulator therapy (HEMT)Inconclusive diagnosis (CFSPID)ModulatorsNewborn screening (NBS)

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...